Derivative exercise or conversion — not an open-market buy.
Loading…
Planned for Aug 14, 2026 · Notice filed Aug 14, 2026
A top manager at AbbVie told the SEC they plan to sell $8.18M of AbbVie shares around Aug 14, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
AbbVie's CHIEF BUS/STRAT OFFICER sold $8.18M of AbbVie shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.